256381-13-2

Usage

Also known as

4-bromomethcathinone

Classification

Substituted cathinone class

Type

Psychoactive drug and designer drug
3. Effects on the central nervous system

Similar to

Amphetamines and MDMA
4. Usage

Commonly used as

Recreational drug

Methods of ingestion

Oral, inhalation, or injection
5. Stimulating and psychedelic effects
Increased energy
Mental alertness
Euphoria
6. Potential negative effects
Increased heart rate
Elevated blood pressure
Neurotoxicity
7. Legal status

Potential for abuse

High

Adverse health effects

Present

Illegal in many countries

Yes

Listed as controlled substance

Yes

Upstream product

• 42186-06-1 2-(4-Bromophenyl)propionitrile 
• 16532-79-9 4-Bromophenylacetonitrile 
• 582-22-9 2-phenylpropylamine 

Downstream Products

• 211311-65-8 propane-2-sulfonic acid (2-(4-bromo-phenyl)-propyl)-amide 
• 211314-91-9 1-[(1-tert-butoxycarbonylamino-1-methyl)ethyl]-4-bromobenzene 
• 256380-78-6 N-2-(4-Bromophenyl)propyl-N,N-dimethylurea 
• 1338096-94-8 7-bromo-4-methyl-1,2,3,4-tetrahydroisoquinoline 
• 256380-79-7 N-2-(4-bromophenyl)propyl-N,N-diethylurea 
• 211311-95-4 LY 404187 
• 211315-23-0 2-(4-(3-Thienyl)phenyl)-N-(t-butyloxycarbonyl)propyl Amine 
• 211315-22-9 N-2-(4-(thien-3-yl)phenyl)propyl amine 

Relevant academic research and scientific papers

NRF2 ACTIVATOR

Provided are tetrahydroisoquinoline derivatives as Nrf2 activators.

New compounds, pharmaceutical compositions and uses thereof

The invention relates to new compounds of the formula I to their use as medicaments, to methods for their therapeutic use and to pharmaceutical compositions containing them.

Synthesis, biological evaluation and molecular modelling of sulfonohydrazides as selective PI3K p110α inhibitors

A series of 2-methyl-5-nitrobenzenesulfonohydrazides were prepared and evaluated as inhibitors of PI3K. An isoquinoline derivative shows good selectivity for the p110α isoform over p110β and p110δ, and also demonstrates good in vitro activity in a cell pr

2,5-DIOXOIMIDAZOLIDIN-4-YL ACETAMIDES AND ANALOGUES AS INHIBITORS OF METALLOPROTEINASE MMP12.

The invention provides compounds of formula (I) in which L, X, Y, Z1, Z2, R1, R2, R3 and G2 have the meanings defined in the specification; processes for their preparation; pharmaceutical c